For millions of women, the onset of perimenopause and menopause is a clinical desert. Symptoms like hot flashes, sleep disruption, and mood changes are often dismissed or met with fragmented, hard-to-access care. Evernow, a virtual care platform founded in 2019, is betting that a subscription model with 24/7 access to menopause-certified clinicians can finally map a consistent path through it [PERPLEXITY SONAR PRO BRIEF]. The company has raised over $52.5 million, including a $28.5 million Series A led by New Enterprise Associates, to build an all-inclusive healthcare service for women over 40 [Fierce Healthcare, May 2022].
A DARPA veteran's pivot to patient care
Founder and CEO Dr. Alicia Jackson holds a PhD in engineering from MIT and previously served as Deputy Director of the Biological Technologies Office at DARPA [PERPLEXITY SONAR PRO BRIEF]. Her pivot from defense research to direct patient care is aimed at applying systems-level thinking to a neglected area of medicine. Jackson has also been appointed Director of the Advanced Research Projects Agency for Health (ARPA-H), a role she assumed in October 2025 [POLITICO, October 2025]. This dual position underscores a unique profile, bridging high-level biomedical innovation policy with the operational demands of running a venture-backed telehealth company.
The evidence-based, all-access wedge
Evernow's clinical approach is its primary differentiator. The company emphasizes that its care is evidence-based and safety-oriented, offering both hormone therapy and non-hormonal options after individualized risk assessments [PERPLEXITY SONAR PRO BRIEF]. Its internal studies claim significant results, including a massive decrease in symptom severity for patients using menopausal hormone therapy [katiecouric.com]. The service model is built on unlimited access. For a membership fee starting at $49 per month, patients get a personalized care plan, medication management, and 24/7 messaging support with clinicians [USA Today, February 2024].
| Metric | Value |
|---|---|
| Series A (2022) | $28.5M |
| Total Disclosed Funding | $52.5M |
The go-to-market strategy leans heavily on direct-to-consumer subscription fees, but the company has signaled a move toward broader access. A strategic partnership with Talkspace aims to enhance integrated mental health support, suggesting an early play for embedded, B2B2C distribution beyond pure out-of-pocket payments.
Navigating a competitive and regulated landscape
The market for digital menopause care is becoming crowded, with players like Midi Health, Gennev, and Alloy also vying for patients. Evernow's bet rests on a combination of clinical rigor, always-on access, and brand visibility. Its roster of celebrity investors, including Gwyneth Paltrow, Drew Barrymore, and Cameron Diaz, has provided cultural cachet and helped destigmatize the conversation around menopause [The Information, May 2022]. Success will depend on demonstrating superior patient outcomes and retention at scale.
The regulatory context is another critical factor. While the service is virtual, the prescriptions it manages are serious medications. Evernow's emphasis on being "safety-oriented" is a necessary stance in a category where treatment decisions carry long-term health implications [PERPLEXITY SONAR PRO BRIEF]. The company's ability to maintain rigorous clinical protocols and transparent outcome reporting as it scales will be a key marker of its sustainability.
The patient population and the standard of care
The disease state here is the menopausal transition, affecting women typically over the age of 40. The patient population is vast, historically underserved, and often spends years navigating a patchwork of general practitioners, gynecologists, and online forums without a coordinated care plan. Symptoms range from vasomotor disturbances like hot flashes and night sweats to psychological effects like anxiety and cognitive changes, all of which can significantly impair quality of life.
The standard of care today is fragmented and often inaccessible. Many women report that their concerns are minimized during primary care visits. Access to a menopause specialist can involve long wait times, geographic limitations, and lack of insurance coverage. This gap between the prevalence of symptoms and the availability of informed, consistent care is the core problem Evernow is attempting to solve with its virtual, specialist-led model.
What to watch in the next twelve months
The coming year will test several facets of Evernow's model. The operational balance for founder Alicia Jackson, who leads both Evernow and ARPA-H, will be closely watched. Clinically, the publication of peer-reviewed data from its internal studies would provide valuable external validation for its evidence-based claims. Commercially, the expansion of the Talkspace partnership and the pursuit of additional employer or payer contracts will indicate whether the company can move beyond a purely DTC model to achieve wider population reach.